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Abstract A new phagemid cloning vector for positive selection
of recombinants, pBa-7, was constructed which contains an
active barnase gene encoding the cytotoxic ribonuclease from
Bacillus amyloliquefaciens, under control of the lac promoter.
PBa-7 is a derivative of the high-copy number pBluescript II
KS+ phagemid in which the modified barnase killer gene has
been fused downstream from the lac promoter of the pBluescript
II KS+ multiple restriction site. When a lacIq-negative
Escherichia coli strain is transformed by this vector, the active
barnase blocks bacterial growth by massive RNA destruction [1].
However, if barnase is inactivated by insertion of a foreign DNA
fragment into the multirestriction site of the vector, this
recombinant plasmid no longer interferes with the host viability.
The positive selection of recombinant clones is highly efficient
and bench manipulations are considerably simplified. When E.
coli transformants are plated out on rich medium with ampicillin,
only cells containing recombinant plasmids give rise to colonies.
In a lacIq-positive host, the positive selection is IPTG-dependent.
Therefore, pBa-7 phagemid can be amplified and prepared in
large quantities from lacIq-positive E. coli hosts. Hence, pBa-7
seems to be suitable for most genetic engineering manipulations.
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1. Introduction
Positive selection cloning vectors are e⁄cient tools simplify-
ing in vitro DNA recombination procedures. A variety of
plasmid vectors for positive selection has been described.
They rely on the inactivation of either a lethal gene [2^5], a
lethal site [6], a dominant function conferring the cell sensi-
tivity to metabolites [7,8] or a repressor of an antibiotic-re-
sistance function [9]. However, most of these vectors are not
well-adapted for general use due to their large size, the limited
range of useful restriction sites and the need for speci¢c host
strains or culture medium.
Recently, we described a plasmid vector (pMT440) which
utilizes the toxic e¡ect of the bacterial ribonuclease barnase
from Bacillus amyloliquefaciens for positive selection of re-
combinant clones [1]. In the presence of the co-expressed bar-
nase inhibitor barstar, pMT440 may be carried in any Esche-
richia coli harboring the lacIq gene. The vector is lethal,
however, when the tac promoter in front of the barnase
gene is induced by IPTG. For lacIq-negative E. coli strains,
pMT440 is lethal without induction. The multirestriction site
(MRS) of pUC19 was inserted into the barnase gene in place
of the Val-36 codon, a site which does not alter the lethal
e¡ects of barnase [1]. Hence, this pMT440 contained the bar-
nase-barstar cassette, the entire pUC19 polylinker under the
control of the tac promoter and a vector fragment containing
the ori and the ampicillin-resistance gene of the pUC19 plas-
mid. Uncut or re-ligated pMT440 does not support growth,
whereas bacteria survive when transformed by plasmids con-
taining inserts in the barnase gene, since the insertion of a
foreign sequence into the center of the barnase gene inacti-
vates the enzyme.
However, pMT440 still has some disadvantages: (i) the
MRS is not £anked for the annealing of universal sequencing
primers and (ii) it not only lacks the f1 origin, necessary for
obtaining single-stranded DNA, but (iii) also lacks T3/T7 sites
for in vitro transcription. These drawbacks could be overcome
by the creation of a new vector using barnase as a condition-
ally lethal gene in connection with the pBluescript II KS+
phagemid vector. For the construction of pBa-7, we ampli¢ed
the barnase gene with speci¢c primers for the £anking SacI
sites and cloned it into pBluescript II KS+ again using SacI
sites. The barnase gene was thus placed directly behind the
polylinker. Cloning of an insert into the polylinker of this new
vector causes a frame shift and/or inactivation of the barnase
gene. In the absence of the leader peptide sequence in the
barnase gene and the barnase inhibitor barstar, the intracel-
lular active barnase was raised to toxic concentrations which
interfered with the plasmid ampli¢cation. A special mutated
barnase gene with six additional amino acids in place of the
GTG codon of Val-36, encoding an enzyme with a slightly
reduced ribonuclease activity [10], was used to solve this prob-
lem.
The new phagemid vector pBa-7 not only o¡ers the same
possibilities as the pBluescript II KS+ vector for gene manip-
ulations, but also has the advantage that only recombinant
clones give rise to viable colonies which would otherwise be
discriminated from non-recombinant ones with the blue white
screening technique [11,12], thus allowing direct positive selec-
tion.
2. Materials and methods
2.1. Construction of the pBa-7 phagemid vector
Plasmid pBa-7 was constructed as follows: SacI sites were created
by PCR on both sides of the barnase-barstar cassette. Ampli¢cation
was carried out with plasmid pMT438a [10] and with two oligonucleo-
tide primers, 5P-TGTGACAGAGCCGAAGTTCAACACGTT and
5P-CATCTCCGAGTCTCGTTTAAGAAAGTATGATGGT. The
SacI-digested PCR product was cloned into the SacI site of pBlue-
script II KS+ using standard procedures and XL-1blue competent
cells (recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac (FP proAB
lacIqZDM15 Tn10 (Tetr)) as described in [13]. The sequence of the 33
base oligonucleotide was chosen so that after elimination of the SacII
site in the MRS of the vector using SacII and the Klenow fragment
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(Life Technologies, Karlsruhe, Germany), as described by [13], the
barnase gene could be fused in frame downstream from the MRS
of pBluescript II KS+. The recombinant construct consisting of the
barnase gene fused with the encoding sequence of the 54 N-terminal
amino acids of lacZ, the MRS of pBluescript II KS+ and barstar was
designated pBa-2.0 (Fig. 1). Thereafter, a spontaneous PCR mutation
in the barstar gene could be selected in which the sequence GAGCTT
(position 837 in the sequence of the barnase gene: [14]) was trans-
formed into the SacI site GsAGCTC. Using this SacI site, a DNA
fragment encoding amino acids 25^89 of the barstar gene was re-
moved. In this vector, designated pBa-3s, only an inactive barstar
peptide consisting of the ¢rst 24 N-terminal amino acids of the barstar
is synthesized. A subsequent PCR ampli¢cation step with the two
oligonucleotide probes 5P-TGTGACAGAGCTCGCACAGGTTAT-
CAACACGTT and 5P-GACCGCGGGAGCTCACACTTTATGTA-
AAGCTGAA was performed for complete removal of the barstar
sequence. The construct pBa-6s (not shown on Fig. 1) was obtained
by exchange cloning the SacI-digested PCR product into the SacI cut
pBa-3. The pBa-6 plasmid possesses two respective SmaI, EcoRI and
HindIII sites, one in the MRS and the other in the central part of the
barnase gene. In order to preserve only one unique SmaI, EcoRI and
HindIII site in the MRS, the central SmaI, EcoRI and HindIII sites
were modi¢ed by overlap extension PCR-directed mutagenesis as de-
scribed [15], using the following two mutagenizing oligonucleotides
for two rounds of site-directed mutagenesis, 5P-CTGCAAGGTTC-
CCTTTTGATGCTAAGCTCTTCTGAAATTCCC (for EcoRI and
HindIII) and 5P-GCTTTTGCCCGGAAGTTTGCCTTCCC (for
SmaI).
Fig. 1. Construction of the pBa-7 phagemid vector. The location of unique restriction sites in the polylinker, annealing sites of the universal
primers, the lacP gene, the barnase gene and the barstar gene are shown. The ampicillin-resistance gene, the ColE1 origin of DNA replication
and f1 origin are not presented. DNA inserts may be sequenced with this pBa-7 vector by using a reverse M13 primer (GGAAACAGCTAT-
GACCATG), T3 primer (AATTAACCCTCACTAAAGGG), KS primer (TCGAGGTCGACGGTATC) and SK primer (CGCTCTAGAAC-
TAGTGGATC).
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2.2. Positive selection cloning with the pBa-7
Total cellular RNA from Karpas 299 cells was extracted using a
single-step isolation technique with Trizol Reagent (Life Technologies,
Karlsruhe, Germany). The cDNA for PCR was synthesized using the
Superscript Preampli¢cation System with oligo(dT)12ÿ18 primers (Life
Technologies, Karlsruhe, Germany). Subsequent PCR was performed
with the BamHI site-£anked human MDC-9-speci¢c primers, 5P-C-
GCGGATCCTTGCTGTCTTGCCACAGACCCGGTATGTGGAG
and 5P-CGCGGATCCTCCGTCCCTCAATGCAGTATTCATTTC-
ATTGTATGT. The 1500 bp PCR fragment was extracted from agar-
ose gels and ligated into BamHI-digested pBa-7 utilizing components
of the Sure Clone Ligation kit (Pharmacia Biotech, Freiburg, Ger-
many). Competent TOP10 E. coli cells (F- mcrA delta(mrr-hsdRMS-
mcrBC) phi-80 lacZ-delta-M15 delta-lacX74 deoR recA1araD139 del-
ta-(ara-leu)7679 galU galK rpsL(StrR) endA1 nupG) from the One
Shot Competent cells kit (Invitrogen, San Diego, CA, USA) were
transformed by using a ligase reaction mixture, plated out and incu-
bated for 14^16 h on LBA plates as described in the manufacturer’s
instructions. Recombinant clones were grown in LBA medium over-
night followed by plasmid DNA extraction with the Qiagen Miniprep
Plasmid Isolation kit (Qiagen, Hilden, Germany). Restriction analysis
with BamHI (Life Technologies, Karlsruhe, Germany) and colony
PCR were performed as described in [13].
2.3. DNA sequencing
All nucleotide sequences were determined by the dideoxy method,
using the BigDye Terminator Cycle Sequencing Ready Reaction kit
(Applied Biosystems, Foster city, CA, USA). Subsequent separation
and analysis were performed on a model ABI PRIZM 310 sequencer
(Applied Biosystems, Foster city, CA, USA).
3. Results and discussion
As the basis for the construction of the positive selection
vector pBa-7, which relies on the lethal e¡ect of barnase, we
choose the phagemid pBluescript II KS+ (Stratagene, Heidel-
berg, Germany). The scheme for the construction of pBa-7 is
presented in Fig. 1. Like most other advanced vectors, the
pBa-7 vector contains a large polylinker which is placed in
front of the sequence of the barnase gene and is translated
together with it. Hence, the polylinker adds 54 N-terminal
amino acids to the recombinant barnase. The insertion of
foreign DNA into the polylinker will lead to an inactivation
of the barnase gene either by the induction of a frame shift or,
when the inserts are of a su⁄cient size, by interruption of the
barnase primary structure. The vector was obtained by clon-
ing a 900 bp PCR fragment of the barnase-barstar cassette,
£anked by SacI sites, into the pBluescript II KS+ which also
contains in its polylinker a SacI site as the last restriction site.
For a reduction of the cytotoxic e¡ect of the barnase lacking
the signal peptide, a mutant gene was used which contained
the six inserted amino acids Glu-Phe-Gln-Lys-Ser-Leu instead
of Val-36 [1,10]. The modi¢ed regions of this construct pBa-2
(Fig. 1) were sequenced and its toxicity for lacIq-negative E.
coli TOP10 cells was tested. However, pBa-2 turned out to be
non-toxic and even the size of colonies was not reduced. This
e¡ect might possibly have been due to the 54 N-terminal
amino acids of barnase representing the polylinker.
A spontaneous deletion mutant could be isolated in which a
DNA fragment from the 3P-end of the barstar gene was omit-
ted. Since this missing part of barstar is responsible for its
inhibitory activity, the resulting construct, pBa-3s (Fig. 1),
was strongly cytotoxic for the E. coli strain TOP10. This in-
dicated that the barstar gene was not necessary in this variant
of the vector design and it was therefore removed. Indeed, the
resulting plasmid pBa-6 was reduced to 3367 bp and had a
high lethal activity which is a prerequisite for the positive
selection of recombinant clones. The pBa-6 vector was further
improved by removal of the disturbing internal EcoRI, Hin-
dIII and SmaI restriction sites from the barnase gene by site-
speci¢c mutagenesis [15] and the resulting vector pBa-7 (Fig.
1) was tested for cloning of DNA fragments.
The insertion of a foreign DNA fragment into the MRS of
pBa-7 should lead to an inactivation of the barnase gene
product. When TOP10 E. coli cells are transformed by liga-
tion without induction by IPTG, recombinant plasmids
should give rise to viable colonies, whereas the parental vector
should be lethal for the host. A 1500 bp fragment of the
reprolysin MDC-9 [16] was obtained by PCR ampli¢cation
with speci¢c primers which were £anked by BamHI sites.
These MDC-9 fragments were treated with BamHI and li-
gated into the BamHI-linearized pBa-7. After transformation
of TOP10 E. coli cells with this construct and incubation on
LB plates supplemented with 100 Wg/ml ampicillin, 19 trans-
formants were picked and their plasmid DNA was isolated.
Restriction analysis with BamHI showed that 18 out of 19
contained recombinant plasmids with inserts of the correct
size (Fig. 2I). 19 Other transformants were analyzed with
bacterial colony PCR using KS and SK universal primers
(Fig. 2II). 18 Of these 19 colonies contained recombinant
plasmids of the correct size.
We also used the pBa-7 vector for the cloning of a 800 bp
Fig. 2. Analysis of 38 individual recombinant inserts cloned using
the positive selection vector pBa-7. (I) Lines 1^19 show BamHI-di-
gested DNA mini-preparations from E. coli TOP10 cells demon-
strating that 18 of the 19 colonies contain a 1500 bp insert encoding
the human reprolysin MDC-9. The arrows indicate the pBa-7 vec-
tor. (II) Lines 1^19 represent the analysis of bacterial colonies by
direct PCR using KS and SK universal primers showing 18 out of
the other 19 TOP10 recombinants containing an 1500 bp insert of
human MDC-9.
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control PCR fragment from the Zero Blunt PCR Cloning kit
(Invitrogen, San Diego, CA, USA) via the EcoRV and SmaI
restriction sites. For all procedures such as ligation and trans-
formation of the competent TOP10 E. coli cells (One Shot
Competent E. coli kit : Invitrogen, San Diego, CA, USA),
the original components of the kit were used according to
the manufacturer’s instructions. HindIII/BamHI restriction
analysis showed that all 20 picked clones obtained using the
EcoRV site and that nine out of 10 transformants obtained by
cloning into the SmaI site were positive and had an insert of
the correct size. These results demonstrate that positive selec-
tion of recombinant clones using pBa-7 seems to function very
e⁄ciently.
The pBa-7 appears to be a suitable vector for general pur-
pose cloning of DNA fragments. It seems likely that the same
selection system could also be used in phages and perhaps in
plasmids for di¡erent hosts. The applied selection strategy
may be regarded as an example of the ‘kill the rest’ approach
by taking advantage of charging vectors with destructive en-
zymes that ensure positive selection of the target clones.
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